Joseph M Curry

8PUBLICATIONS
67CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 12, 2025
Neoadjuvant nivolumab plus carboplatin and paclitaxel in patients with locally advanced resectable squamous cell carcinoma of the head and neck: a phase II, single-arm trial.

Ralph G Zinner, Eric V Mastrolonardo, Jennifer M Johnson

|Nov 25, 2025
Neck Spasms After Lateral Neck Dissection: A Survey of Head and Neck Cancer Patients.

Kelly Bridgham, Teresa Duong, Praneet Kaki

|Sep 11, 2025
Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC.

Pablo Llerena, Hani Samarah, Kathryn Nunes

|Nov 25, 2024
Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma.

Eric V Mastrolonardo, Kathryn L Nunes, Pablo Llerena

|Oct 10, 2024
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysis.

Priyan Bhattacharya, Alban Linnenbach, Andrew P South

|May 26, 2023
Trends in Positive Surgical Margins in cT3-T4 Oral Cavity Squamous Cell Carcinoma.

Kavita Prasad, Michael C Topf, Stephanie Clookey

Pageof 2

Frequent Collaborators

4 joint publications

Athanassios Argiris

4 joint publications

Adam Luginbuhl

4 joint publications

Larry Harshyne

4 joint publications

Jennifer M Johnson